Hamilton Lane Advisors LLC Cytom X Therapeutics, Inc. Transaction History

Hamilton Lane Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$5.17 - $8.91 $102,872 - $177,291	-19,898 Closed	0 $0
Q1 2019 Apr 22, 2019	SELL	$9.5 - $19.16 $464,122 - $936,061	-48,855 Reduced 71.06%	19,898 $214,000
Q4 2018 Jan 23, 2019	SELL	$12.69 - $18.61 $152,280 - $223,320	-12,000 Reduced 14.86%	68,753 $1.04 Million
Q2 2018 Jul 31, 2018	SELL	$21.38 - $29.68 $529,796 - $735,470	-24,780 Reduced 23.48%	80,753 $2,000
Q1 2018 May 03, 2018	BUY	$21.76 - $34.22 $1.2 Million - $1.89 Million	55,139 Added 109.42%	105,533 $3,000
Q4 2017 Jan 17, 2018	BUY	$19.0 - $23.09 $418,912 - $509,088	22,048 Added 77.78%	50,394 $1.06 Million
Q3 2017 Oct 16, 2017	BUY	$13.53 - $18.17 $383,521 - $515,046	28,346	28,346 $515,000

50.7M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.